MENU
+Compare
RXL
ETF ticker: NYSE ARCA
AS OF
Apr 3, 01:50 PM (EDT)
Price
$47.88
Change
+$0.06 (+0.13%)
Net Assets
80.75M

RXL stock forecast, quote, news & analysis

The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the S&P Health Care Select Sector Index... Show more

Category: #Trading
RXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Ad is loading...
A.I.Advisor
a Summary for RXL with price predictions
Apr 02, 2025

RXL in downward trend: price dove below 50-day moving average on March 25, 2025

RXL moved below its 50-day moving average on March 25, 2025 date and that indicates a change from an upward trend to a downward trend. In of 42 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RXL as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for RXL turned negative on March 10, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 10-day moving average for RXL crossed bearishly below the 50-day moving average on March 21, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RXL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 51 cases where RXL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RXL advanced for three days, in of 334 cases, the price rose further within the following month. The odds of a continued upward trend are .

RXL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 276 cases where RXL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG), Elevance Health (NYSE:ELV).

Industry description

The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the S&P Health Care Select Sector Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index includes equity securities of companies from the following GICS industries: health care equipment & supplies, health care providers & services; health care technology; biotechnology; pharmaceuticals; and life sciences tools & services. The fund is non-diversified.

Market Cap

The average market capitalization across the ProShares Ultra Health Care ETF is 90.07B. The market cap for tickers in the group ranges from 9.23B to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is TECH at 9.23B.

High and low price notable news

The average weekly price growth across all stocks in the ProShares Ultra Health Care ETF was 8%. For the same ETF, the average monthly price growth was 15%, and the average quarterly price growth was 47%. MCK experienced the highest price growth at 5%, while MRNA experienced the biggest fall at -12%.

Volume

The average weekly volume growth across all stocks in the ProShares Ultra Health Care ETF was -7%. For the same stocks of the ETF, the average monthly volume growth was -24% and the average quarterly volume growth was 18%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 57
Price Growth Rating: 52
SMR Rating: 61
Profit Risk Rating: 56
Seasonality Score: -3 (-100 ... +100)
View a ticker or compare two or three
RXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Fundamentals
Details
Category
Trading--Leveraged Equity
Address
ProShares Trust7501 Wisconsin Avenue,Suite 1000Bethesda
Phone
N/A
Web
www.proshares.com